Blocking of the Ubiquitin-Proteasome System Prevents Inflammation-Induced Bone Loss by Accelerating M-CSF Receptor c-Fms Degradation in Osteoclast Differentiation
Anti-osteoporotic activity of a blocker of the ubiquitin-proteasome system, bortezomib, has known to be achieved by directly opposed action in increased bone formation by osteoblasts and in decreased bone destruction by osteoclasts. However, the mechanisms underlying the proteasome blocker inhibitio...
Main Authors: | Kyunghee Lee, Mi Yeong Kim, Heejin Ahn, Han-Sung Kim, Hong-In Shin, Daewon Jeong |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2017-09-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/18/10/2054 |
Similar Items
-
Anti-c-fms Antibody Prevents Osteoclast Formation and Bone Resorption in Co-Culture of Osteoblasts and Osteoclast Precursors In Vitro and in Ovariectomized Mice
by: Yasuhiko Nara, et al.
Published: (2020-08-01) -
Psoralen and Bakuchiol Ameliorate M-CSF Plus RANKL-Induced Osteoclast Differentiation and Bone Resorption Via Inhibition of AKT and AP-1 Pathways in Vitro
by: Lijuan Chai, et al.
Published: (2018-08-01) -
Wheat seedling extract and its constituents attenuate RANKL-induced differentiation and fusion of osteoclasts and bone resorption
by: HanGyeol Lee, et al.
Published: (2023-09-01) -
Zika virus infects human osteoclasts and blocks differentiation and bone resorption
by: Noreen Mumtaz, et al.
Published: (2022-12-01) -
The effects of seeding density and osteoclastic supplement concentration on osteoclastic differentiation and resorption
by: Stefan J.A. Remmers, et al.
Published: (2023-06-01)